(Q42983442)

12 November 2017

title

Liver injury during highly active antiretroviral therapy: the effect of hepatitis C coinfection (English)

1 reference

12 November 2017

1 reference

Maurizio Bonacini

1

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Clinical Infectious Diseases

12 November 2017

published in

1 reference

12 November 2017

volume

38 Suppl 2

1 reference

12 November 2017

page(s)

S104-8

1 reference

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

12 November 2017

cites work

1 reference

Balancing safety of dietary supplements with the free market

21 January 2018

1 reference

Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy

21 January 2018

1 reference

Hepatitis C in the HIV-Infected Person

21 January 2018

1 reference

Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues

21 January 2018

1 reference

Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus

21 January 2018

1 reference

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

21 January 2018

1 reference

Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection

21 January 2018

1 reference

Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome

21 January 2018

1 reference

Liver toxicity in epidemiological cohorts

21 January 2018

1 reference

Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution.

21 January 2018

1 reference

Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects

21 January 2018

1 reference

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

21 January 2018

1 reference

Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients

21 January 2018

1 reference

Hyperlactataemia syndromes associated with HIV therapy

21 January 2018

1 reference

Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more

21 January 2018

1 reference

Risk of HAART therapy in hepatitis C.

21 January 2018

1 reference

Liver toxicity caused by nevirapine

21 January 2018

1 reference

Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

21 January 2018

1 reference

Low Frequency of Severe Hepatotoxicity and Association With HCV Coinfection in HIV-Positive Patients Treated With HAART

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/381453

1 reference

12 November 2017

1 reference